Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model
Species
Mouse
Source
Corneal grafts
Condition
Corneal transplantation
Technology
mRNA-seq
Groups
Control (corneal grafts with PBS injection 14 days after high-risk corneal transplantation, n = 3); Anti-CD80/86(corneal grafts with CD80/86 antibodies injection 14 days after high-risk corneal transplantation, n = 3)
Citation
Zhu, Jun et al. "Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model." Scientific reports vol. 12,1 (2022): 4853. doi:10.1038/s41598-022-08949-9
